UpdatesPress Release
IOL Chemicals reports record Q1 FY27 results: Revenue up 37.1% to ₹756.3 Cr, PAT surged 89.9% to ₹64.5 Cr.
IOL Chemicals and Pharmaceuticals LimitedIOLCP · Filed with the exchange
Performance driven by improved capacity utilization, product mix.
Clopidogrel API received NMPA approval in China, expanding market access.
No comments yet. Be the first.